Latest News

Keep up to date with the latest news from our team at the Kolling Institute of Medical Research. By subscribing to our newsletter, you’ll discover more about our dedicated teams and their latest findings. You’ll have access to information about upcoming events and you’ll hear about opportunities to support our research.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kolling researchers part of elite group in fight against heart disease

Kolling researchers part of elite group in fight against heart disease

Two Kolling Institute researchers have welcomed a significant funding boost through a large NSW Government program to help tackle Australia’s number one killer, heart disease. Professors Gemma Figtree and Martin Ugander have each been awarded a $750,000 grant to encourage researchers to find breakthroughs and help establish NSW as a centre for research excellence. The funding is part of..... Read more

Category: Funding support

Northern Sydney leading the way with arthritis research and clinical care

Northern Sydney leading the way with arthritis research and clinical care

The latest exciting research into musculoskeletal disease has been unveiled during the inaugural Northern Lights showcase. Close to 200 people attended the jam packed event in the Kolling auditorium, including clinicians, researchers and many people living with arthritic pain. RNSH Head of Rheumatology Professor Lyn March addressed the event, detailing the devastating cost of the diseas..... Read more

Category: New Treatment

Recognition for the Kolling Director

Recognition for the Kolling Director

The Kolling’s Director of Research Professor Carolyn Sue has been awarded a Member of the Order of Australia (AM) in this year’s Queen’s Birthday Honours for her significant service to medicine, particularly mitochondrial disease. Carolyn is a highly accomplished neurologist and is internationally regarded for her work in both Parkinson’s and mitochondrial disease. Recently appointed to ..... Read more

New world leading technology to guide future bowel cancer treatment

New world leading technology to guide future bowel cancer treatment

Research capabilities within the Kolling Institute have been significantly broadened with new technology to assist the examination of bowel cancer. Representatives from Sydney University, the Kolling and Bowel Cancer Australia attended the official opening of the mass spectrometry core lab – the first of its type on a hospital campus and one of the best analytical facilities in the worl..... Read more

Category: World-leading technology, New Treatment

Newsletter

Newsletter

Read more

Category: Newsletters

Newsletter

Newsletter

Read more

Category: Newsletters

2018 Year In Review

2018 Year In Review

Read more